By utilizing in vitro assays and in vivo animal models, we demonstrated that AEP-cleaved G3BP1 modulates tumor cell survival, and that inhibition of AEP sensitizes cancer cells to chemotherapeutic drugs. Here, G3BP1 is linked to neoplasm.